$0.133
+0 (+0%)
At Close: Jun 03, 2026
Accelmed Partners Raises $400 Million to Invest in Commercial Stage HealthTech
07:00am, Wednesday, 17'th Mar 2021
AVENTURA, Fla.--(BUSINESS WIRE)--Accelmed fund II
STRATA Skin Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021
08:00am, Wednesday, 10'th Mar 2021
HORSHAM, Pa., March 10, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing an
STRATA Skin Sciences Announces Expanded Distribution Agreement in China with Wuhan Miracle Laser Systems, Inc.
08:00am, Tuesday, 09'th Mar 2021
New Agreement Expands STRATA's Global Reach and Brings Successful Recurring Revenue Model to the Chinese Dermatology Market New Agreement Expands STRATA's Global Reach and Brings Successful Recurring
SSKN Stock Price Increases Over 10% Pre-Market: Why It Happened
05:30am, Tuesday, 02'nd Mar 2021
The stock price of STRATA Skin Sciences Inc (NASDAQ: SSKN) is trading at over 10% pre-market. This is why it happened.
STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:35pm, Monday, 01'st Mar 2021
HORSHAM, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (the “Company”) a medical technology company in dermatology and plastic surgery dedicated to developing,
STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results and Operational Metrics
08:05am, Tuesday, 12'th Jan 2021
Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 million Preliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 million Worl
STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference
11:15am, Wednesday, 06'th Jan 2021
HORSHAM, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated
STRATA Skin Sciences, Inc. Announces Successful Renewal of Note Payable
08:00am, Monday, 28'th Dec 2020
HORSHAM, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated
Where Do Hedge Funds Stand On Strata Skin Sciences, Inc. (SSKN)?
10:46am, Friday, 27'th Nov 2020
In this article we will check out the progression of hedge fund sentiment towards Strata Skin Sciences, Inc. (NASDAQ:SSKN) and determine whether it is a good investment right now. We at Insider Monkey
STRATA Skin Sciences, Inc. (SSKN) CEO Dolev Rafaeli on Q3 2020 Results - Earnings Call Transcript
01:52pm, Tuesday, 10'th Nov 2020
STRATA Skin Sciences, Inc. (SSKN) CEO Dolev Rafaeli on Q3 2020 Results - Earnings Call Transcript
Strata Skin Sciences: Q3 Earnings Insights
08:31am, Tuesday, 10'th Nov 2020
Shares of Strata Skin Sciences (NASDAQ:SSKN) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell 33.33% year over year to ($0.04), which were in line w
STRATA Skin Sciences Reports Third Quarter 2020 Financial Results
08:00am, Tuesday, 10'th Nov 2020
HORSHAM, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, comme
STRATA Skin Sciences to Present at Three Upcoming Investor Conferences
08:00am, Thursday, 05'th Nov 2020
HORSHAM, Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, comme
STRATA Skin Sciences to Report Third Quarter 2020 Financial Results on November 10, 2020
08:00am, Tuesday, 03'rd Nov 2020
HORSHAM, Pa., Nov. 03, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated
Delivers fastest results with fewest adverse events compared to topical, traditional UV, biologic and systemic therapies Providing a better solution for I ntegrated H ealth S ystems and Capitation h
Sign In
Buy SSKN